20
Cilag Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IRON SUCROSE DRUG SUBSTANCE, with a corresponding US DMF Number 19544.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 17, 2022, and payment made on March 14, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II